Cleared Traditional

K950634 - CANDELA SHEATH SETS

K950634 is the FDA 510(k) clearance for CANDELA SHEATH SETS by Candela Laser Corp.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 16-day FDA review.

K950634 · Candela Laser Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1995
Decision
16d
Days
Class 2
Risk

K950634 is an FDA 510(k) clearance for the CANDELA SHEATH SETS. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Candela Laser Corp. (Wayland, US). The FDA issued a Cleared decision on March 1, 1995 after a review of 16 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Candela Laser Corp. devices

Submission Details

510(k) Number K950634 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 1995
Decision Date March 01, 1995
Days to Decision 16 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
109d faster than avg
Panel avg: 125d · This submission: 16d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 586
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K950634.
CORDIS BRITE TIP, ENVOY GUIDING CATHETER
K952185 · Cordis Corp. · Aug 1995
SCIMED(R) TRIDUIGE(R) GUIDE CATHETERS
K946204 · Scimed Life Systems, Inc. · Mar 1995
SCIMED 6 FRENCH MICRO-MAX(TM) GUIDE CATHETER
K950094 · Scimed Life Systems, Inc. · Mar 1995
CANDEKA DUKATIR SETS
K950635 · Candela Laser Corp. · Mar 1995
5F ENVOY(TM) GUIDING CATHETER
K945705 · Cordis Neurovascular, Inc. · Feb 1995
SCHNEIDER PINK POWER SOFTIP GUIDNIG CATHETER
K943622 · Boston Scientific Scimed, Inc. · Nov 1994